Skip to main content
Premium Trial:

Request an Annual Quote

Biocept, MD Anderson Expand Ovarian Cancer Collaboration

NEW YORK (GenomeWeb) — Biocept said today that it has expanded its collaboration with the University of Texas MD Anderson Cancer Center in the area of ovarian cancer.

San Diego-based Biocept specializes in the analysis of biomarkers in cell-free circulating tumor DNA and circulating tumor cells. The expansion of its collaboration with MD Anderson follows findings from a recent study in which MD Anderson researchers successfully used Biocept's OncoCEE platform in a mouse model of ovarian cancer. The results of the study were published in July in Cancer Cell.

The OncoCEE microfluidic device captures CTCs then evaluates the expression of the genomic marker HER3 (human epidermal growth factor 3) in ovarian cancer cells to provide insight into alternative routes of metastasis, Biocept said. According to a company spokesperson, Biocept and MD Anderson had previously collaborated on breast cancer studies.

In a statement, Biocept President and CEO Michael Nall said that Biocept believes the findings from the recently published study are valuable "as they help in our understanding of ovarian cancer metastasis and how to improve clinical management of these patients." He added that "partnerships with top-tier centers such as [MD Anderson] are a pillar of our growth strategy and we will continue to work to further develop our relationships with academic and research partners."

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.